Adam T. Hill

19.5k total citations · 3 hit papers
149 papers, 8.0k citations indexed

About

Adam T. Hill is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Adam T. Hill has authored 149 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Pulmonary and Respiratory Medicine, 61 papers in Epidemiology and 21 papers in Emergency Medical Services. Recurrent topics in Adam T. Hill's work include Cystic Fibrosis Research Advances (84 papers), Tracheal and airway disorders (37 papers) and Neonatal Respiratory Health Research (36 papers). Adam T. Hill is often cited by papers focused on Cystic Fibrosis Research Advances (84 papers), Tracheal and airway disorders (37 papers) and Neonatal Respiratory Health Research (36 papers). Adam T. Hill collaborates with scholars based in United Kingdom, Italy and Spain. Adam T. Hill's co-authors include James D. Chalmers, Aran Singanayagam, M Murray, Diana Bilton, M. C. Pasteur, Ahsan R. Akram, John R. W. Govan, Brian J. McHugh, Robert A. Stockley and J T Macfarlane and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Adam T. Hill

144 papers receiving 7.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

2009 999 citations Wei Shen Lim, Simon Baudouin et al. Thorax profile →
British Thoracic Society guideline for non-CFbronchiectasis

2010 727 citations Adam T. Hill et al. Thorax profile →
The Bronchiectasis Severity Index. An International Derivation and Validation Study

2014 665 citations James D. Chalmers, Pieter Goeminne et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam T. Hill United Kingdom	44	4.8k	3.4k	899	704	660	149	8.0k
Stefano Aliberti Italy	50	5.1k 1.1×	3.5k 1.0×	1.3k 1.4×	718 1.0×	514 0.8×	350	9.6k
James D. Chalmers United Kingdom	63	8.9k 1.9×	5.2k 1.5×	1.2k 1.3×	1.4k 2.0×	1.2k 1.8×	483	14.4k
Eva Polverino Spain	40	2.8k 0.6×	2.6k 0.8×	873 1.0×	422 0.6×	295 0.4×	166	5.1k
Mark Woodhead United Kingdom	40	2.3k 0.5×	4.9k 1.4×	1.6k 1.7×	441 0.6×	216 0.3×	105	7.3k
Antoni Torres Spain	54	3.1k 0.6×	6.6k 1.9×	2.7k 3.0×	338 0.5×	290 0.4×	171	9.8k
Rosario Menéndez Spain	50	2.1k 0.4×	5.1k 1.5×	1.8k 2.0×	270 0.4×	212 0.3×	237	7.8k
Jordi Dorca Spain	44	1.6k 0.3×	3.5k 1.0×	1.1k 1.3×	402 0.6×	160 0.2×	143	5.5k
Aran Singanayagam United Kingdom	36	1.4k 0.3×	1.9k 0.6×	643 0.7×	429 0.6×	207 0.3×	89	3.9k
Kristina Crothers United States	50	2.1k 0.4×	4.7k 1.4×	589 0.7×	785 1.1×	352 0.5×	216	9.8k
Torsten Bauer Germany	36	2.4k 0.5×	2.4k 0.7×	1.7k 1.9×	350 0.5×	132 0.2×	143	5.6k

Countries citing papers authored by Adam T. Hill

Since Specialization

Citations

This map shows the geographic impact of Adam T. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam T. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam T. Hill more than expected).

Fields of papers citing papers by Adam T. Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam T. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam T. Hill. The network helps show where Adam T. Hill may publish in the future.

Co-authorship network of co-authors of Adam T. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Adam T. Hill. A scholar is included among the top collaborators of Adam T. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam T. Hill. Adam T. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bradley, Judy, Kathryn M. Ferguson, Katherine O’Neill, et al.. (2022). Clinimetric Properties of Outcome Measures in Bronchiectasis. Annals of the American Thoracic Society. 20(5). 648–659. 2 indexed citations

Sloan, Derek J., Wilna Oosthuyzen, Till T. Bachmann, et al.. (2021). MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection. British Journal of Clinical Pharmacology. 87(8). 3206–3217. 13 indexed citations

Bedi, Pallavi, Yang Zhang, Kim Turnbull, et al.. (2021). Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial. European Respiratory Journal. 58(6). 2004388–2004388. 12 indexed citations

Loebinger, Michael R., Eva Polverino, Francesco Blasi, et al.. (2019). Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1). Pulmonary Pharmacology & Therapeutics. 58. 101834–101834. 7 indexed citations

Sapey, Elizabeth, Jaimin Patel, Hannah Greenwood, et al.. (2019). Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 200(10). 1282–1293. 69 indexed citations

Bedi, Pallavi, Donald J. Davidson, Brian J. McHugh, Adriano G. Rossi, & Adam T. Hill. (2018). Blood Neutrophils Are Reprogrammed in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 198(7). 880–890. 68 indexed citations

Smith, Maeve P., Pallavi Bedi, Andrea Clarke, et al.. (2018). Validation of the Incremental Shuttle Walk Test as a Clinical End Point in Bronchiectasis. CHEST Journal. 154(6). 1321–1329. 6 indexed citations

Akram, Ahsan R., Sunay V. Chankeshwara, Emma Scholefield, et al.. (2018). In situ identification of Gram-negative bacteria in human lungs using a topical fluorescent peptide targeting lipid A. Science Translational Medicine. 10(464). 69 indexed citations

Bedi, Pallavi, James D. Chalmers, Catriona Graham, et al.. (2017). A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa. CHEST Journal. 152(2). 368–378. 27 indexed citations

10.

Chalmers, James D., Pieter Goeminne, Stefano Aliberti, et al.. (2014). The Bronchiectasis Severity Index. An International Derivation and Validation Study. American Journal of Respiratory and Critical Care Medicine. 189(5). 576–585. 665 indexed citations breakdown →

11.

Sidhu, Manjit, Pallavi Mandal, & Adam T. Hill. (2014). Developing drug therapies in bronchiectasis. Expert Opinion on Investigational Drugs. 24(2). 169–181. 6 indexed citations

12.

McDonnell, Melissa J., Pieter Goeminne, John M. Davison, et al.. (2014). Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis. European Respiratory Journal. 44(Suppl 58). P2484–P2484. 1 indexed citations

13.

Mandal, Pallavi, DK Patel, & Adam T. Hill. (2013). A simplified CT scoring system in non cystic fibrosis bronchiectasis. European Respiratory Journal. 42(Suppl 57). P241–P241. 3 indexed citations

14.

Chalmers, James D., et al.. (2012). Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 186(7). 657–665. 290 indexed citations

15.

Jones, Michael E., et al.. (2012). Does an interferon-gamma release assay change practice in possible latent tuberculosis?. QJM. 106(2). 139–146. 4 indexed citations

16.

Chalmers, James D., Joanne Taylor, Aran Singanayagam, et al.. (2011). Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care-Associated Pneumonia: A UK Cohort Study. Clinical Infectious Diseases. 53(2). 107–113. 185 indexed citations

17.

Murray, M, John R. W. Govan, Catherine Doherty, et al.. (2010). A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 183(4). 491–499. 213 indexed citations

18.

Singanayagam, Aran, James D. Chalmers, & Adam T. Hill. (2009). Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia. European Respiratory Journal. 34(4). 932–939. 16 indexed citations

19.

Murray, M, et al.. (2009). Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. European Respiratory Journal. 34(1). 125–131. 139 indexed citations

20.

Lim, Wei Shen, Simon Baudouin, Robert C. George, et al.. (2009). BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 64(Suppl 3). iii1–iii55. 999 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact